Drug Type Small molecule drug |
Synonyms GRC 15300, GRC 17173, GRC-17173 + [3] |
Target |
Action antagonists |
Mechanism TRPV3 antagonists(Transient receptor potential cation channel subfamily V member 3 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuralgia, Postherpetic | Phase 2 | United States | 01 Mar 2012 | |
Neuralgia, Postherpetic | Phase 2 | Czechia | 01 Mar 2012 | |
Neuralgia, Postherpetic | Phase 2 | Hungary | 01 Mar 2012 | |
Neuralgia, Postherpetic | Phase 2 | Poland | 01 Mar 2012 | |
Neuralgia, Postherpetic | Phase 2 | Russia | 01 Mar 2012 | |
Neuralgia, Postherpetic | Phase 2 | Slovakia | 01 Mar 2012 | |
Neuralgia, Postherpetic | Phase 2 | Ukraine | 01 Mar 2012 | |
Musculoskeletal Pain | Phase 1 | United Kingdom | - | |
Neuralgia | Phase 1 | United Kingdom | - | |
Skin Diseases | Phase 1 | India | - |